IS
IS · IS · IS-IS/1/24/172/01
Vaxigrip
ATC J07BB02
Last synced from Icelandic Medicines Agency (Iceland) on
Identification
ManufacturerSanofi Winthrop Industrie
CountryIS (IS)
ATC codeJ07BB02
Dispensing—
ReimbursedNo
SourceIcelandic Medicines Agency (Iceland)
Last synced6/9/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Stungulyf, dreifa í áfylltri sprautu",
"source": "lyfjastofnun",
"atc_raw": "J07BB02",
"marketed": true,
"strength": "15 míkróg",
"ma_number": "IS/1/24/172/01",
"substance": "B/Austria/1359417/2021 like strain-(B/Michigan/01/2021, wild type),A/Darwin/9/2021 (H3N2) - líkur stofn (A/Darwin/9/2021, IVR-228),A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238)",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "45632"
}Related drugs
Other records sharing ATC code J07BB02.
- BEAdjupanrixGlaxoSmithKline Biologicals
- FIAdjupanrixGlaxoSmithKline Biologicals SA
- PLAdjupanrixGlaxoSmithKline Biologicals S.A.
- ISAdjupanrixGlaxoSmithKline Biologicals S.A.*
- DKAdjupanrixGlaxoSmithKline Biologicals S.A.
- CZADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IEAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NLAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Access this data programmatically
Query Vaxigrip and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.